Purdue in deal for Exicure's lead program in psoriasis

Gene regulation company Exicure Inc. (Skokie, Ill.) granted Purdue Pharma L.P. (Stamford, Conn.) exclusive, worldwide rights to its anti-tumor necrosis factor (TNF) candidate

Read the full 237 word article

User Sign In